APUS · Categories · 8-K
APUS - SEC Form 8-K filings
Apimeds Pharmaceuticals US Inc. (APUS) sec form 8-k filings - real-time wire coverage filtered to 8-K only.
Recent 8-K for APUS
- Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - Apimeds Pharmaceuticals US, Inc. (0001894525) (Filer)
- Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Other Events8-K - Apimeds Pharmaceuticals US, Inc. (0001894525) (Filer)
- Amendment: Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits8-K/A - Apimeds Pharmaceuticals US, Inc. (0001894525) (Filer)
- Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits8-K - Apimeds Pharmaceuticals US, Inc. (0001894525) (Filer)
- Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Leadership Update, Other Events, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - Apimeds Pharmaceuticals US, Inc. (0001894525) (Filer)
- Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Other Events8-K - Apimeds Pharmaceuticals US, Inc. (0001894525) (Filer)
- Amendment: Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets8-K/A - Apimeds Pharmaceuticals US, Inc. (0001894525) (Filer)
- Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Leadership Update8-K - Apimeds Pharmaceuticals US, Inc. (0001894525) (Filer)
- Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Leadership Update8-K - Apimeds Pharmaceuticals US, Inc. (0001894525) (Filer)
- Amendment: Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K/A - Apimeds Pharmaceuticals US, Inc. (0001894525) (Filer)
- Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Apimeds Pharmaceuticals US, Inc. (0001894525) (Filer)
- Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Apimeds Pharmaceuticals US, Inc. (0001894525) (Filer)
- Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - Apimeds Pharmaceuticals US, Inc. (0001894525) (Filer)
- Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Apimeds Pharmaceuticals US, Inc. (0001894525) (Filer)
- Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Leadership Update8-K - Apimeds Pharmaceuticals US, Inc. (0001894525) (Filer)
- Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Apimeds Pharmaceuticals US, Inc. (0001894525) (Filer)